Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Marvel Universe titles arriving on Disney+ in IMAX's Expanded Aspect Ratio » 09:37
11/08/21
11/08
09:37
11/08/21
09:37
DIS

Disney

$175.68 /

+5.41 (+3.18%)

, IMAX

Imax

$20.74 /

+1.04 (+5.28%)

Beginning November 12 -…

Beginning November 12 - which also happens to be Disney+ Day - fans will be able to stream some of their favorite Marvel titles in IMAX's (IMAX) Expanded Aspect Ratio at home with IMAX Enhanced on Disney+ (DIS). According to Marvel's website, "IMAX's Expanded Aspect Ratio is 1:90:1, which offers up to 26% more picture for select sequences - meaning more of the action is visible on screen, just as the filmmakers intended. In the future, the collaboration will deliver even more enhanced audio and visual technology to Disney+, including immersive IMAX signature sound by DTS." The 13 titles available at launch include the Disney+ premiere of Marvel Studios' "Shang-Chi and The Legend of The Ten Rings" on November 12th as well as other MCU movies like "Iron Man," "Guardians of the Galaxy," "Guardians of the Galaxy Vol. 2," "Captain America: Civil War," "Doctor Strange," "Thor: Ragnarok," "Black Panther," "Avengers: Infinity War," "Ant-Man and The Wasp," "Captain Marvel," "Avengers: Endgame," and "Black Widow." Reference Link

ShowHide Related Items >><<
IMAX Imax
$20.74 /

+1.04 (+5.28%)

DIS Disney
$175.68 /

+5.41 (+3.18%)

DIS Disney
$175.68 /

+5.41 (+3.18%)

10/25/21 JPMorgan
JPMorgan lowers 2022 Disney+ subscriber estimate to by 21M
10/18/21
Fly Intel: Top five analyst downgrades
10/18/21 MoffettNathanson
Disney price target lowered to $180 from $185 at MoffettNathanson
10/18/21 Barclays
Barclays downgrades Disney on slowing of streaming growth
IMAX Imax
$20.74 /

+1.04 (+5.28%)

10/29/21 Barrington
Imax price target raised to $25 from $22 at Barrington
10/22/21 Wells Fargo
Wells Fargo starts Imax at Overweight with $27 price target
10/22/21 Wells Fargo
Imax initiated with an Overweight at Wells Fargo
10/11/21 B. Riley
Imax price target raised to $30 from $28 at B. Riley
IMAX Imax
$20.74 /

+1.04 (+5.28%)

DIS Disney
$175.68 /

+5.41 (+3.18%)

IMAX Imax
$20.74 /

+1.04 (+5.28%)

DIS Disney
$175.68 /

+5.41 (+3.18%)

IMAX Imax
$20.74 /

+1.04 (+5.28%)

DIS Disney
$175.68 /

+5.41 (+3.18%)

IMAX Imax
$20.74 /

+1.04 (+5.28%)

DIS Disney
$175.68 /

+5.41 (+3.18%)

Over a month ago
Recommendations
Imax price target raised to $25 from $22 at Barrington » 15:48
10/29/21
10/29
15:48
10/29/21
15:48
IMAX

Imax

$18.65 /

-1.44 (-7.17%)

Barrington analyst James…

Barrington analyst James Goss raised the firm's price target on Imax to $25 from $22 and keeps an Outperform rating on the shares to reflect what he sees as an improved outlook for the company following its Q3 report. Goss notes that Imax received an "outsized share of box office" on many of the blockbuster films that have received a theatrical release thus far this year as consumers have preferred the premium formats available from exhibitors. He maintains Imax on the firm's 2021 Research Best Ideas List.

ShowHide Related Items >><<
IMAX Imax
$18.65 /

-1.44 (-7.17%)

IMAX Imax
$18.65 /

-1.44 (-7.17%)

10/22/21 Wells Fargo
Wells Fargo starts Imax at Overweight with $27 price target
10/22/21 Wells Fargo
Imax initiated with an Overweight at Wells Fargo
10/11/21 B. Riley
Imax price target raised to $30 from $28 at B. Riley
10/04/21 B. Riley
Strong openings 'another outlook boost' for exhibition group, says B. Riley
IMAX Imax
$18.65 /

-1.44 (-7.17%)

IMAX Imax
$18.65 /

-1.44 (-7.17%)

IMAX Imax
$18.65 /

-1.44 (-7.17%)

IMAX Imax
$18.65 /

-1.44 (-7.17%)

Earnings
Imax reports Q3 adjusted EPS (8c) , consensus (13c) » 07:25
10/28/21
10/28
07:25
10/28/21
07:25
IMAX

Imax

$20.72 /

-0.46 (-2.17%)

Reports Q3 revenue…

Reports Q3 revenue $56.6M, consensus $56.42M. "Q3 was a major turning point for IMAX. We delivered over $142M in Global Box Office, a clear sign of significant pent up consumer demand with momentum accelerating into a pre-pandemic September performance and all-time company record in October, which is on track to be one of the top ten months in the company's history," said CEO Richard Gelfond. "The power of the IMAX theatrical window for blockbuster films is clear as we continue to draw moviegoers to the theaters, gain market share, and grow our relationships with local exhibitors, studios, and filmmakers. As anticipated, the domestic market continued its recovery with sequential growth in box office. Local language box office was also a strong performer which already eclipsed our record breaking 2019 local language box office. We are seeing greater confidence in the overall slate as well, as the IMAX-friendly franchise-heavy schedule has solidified through 2022. We feel confident that the table is set for a continued rebound in domestic and international blockbuster moviegoing which is reflected in our decision to opportunistically repurchase shares. With solid operating momentum, strong market share and multiple tentpole films set to be released in the remainder Q4 and 2022, IMAX is well positioned to deliver and strengthen our position as one of the world's premier entertainment experience."

ShowHide Related Items >><<
IMAX Imax
$20.72 /

-0.46 (-2.17%)

IMAX Imax
$20.72 /

-0.46 (-2.17%)

10/22/21 Wells Fargo
Wells Fargo starts Imax at Overweight with $27 price target
10/22/21 Wells Fargo
Imax initiated with an Overweight at Wells Fargo
10/11/21 B. Riley
Imax price target raised to $30 from $28 at B. Riley
10/04/21 B. Riley
Strong openings 'another outlook boost' for exhibition group, says B. Riley
IMAX Imax
$20.72 /

-0.46 (-2.17%)

IMAX Imax
$20.72 /

-0.46 (-2.17%)

IMAX Imax
$20.72 /

-0.46 (-2.17%)

IMAX Imax
$20.72 /

-0.46 (-2.17%)

Initiation
Wells Fargo starts Imax at Overweight with $27 price target » 06:35
10/22/21
10/22
06:35
10/22/21
06:35
IMAX

Imax

$20.54 /

-0.37 (-1.77%)

Wells Fargo analyst…

Wells Fargo analyst Steven Cahall initiated coverage of Imax with an Overweight rating and $27 price target. He sees both consumers and studios pushing the theatrical experience to be "an experience" and believes this "premiumization" of movie-going should drive IMAX upward as a percentage of the box office, Cahall tells investors. He is bullish on the outlook for installs, citing his premiumization thesis combined with a strong film slate ahead and the company's international exposure, Cahall added.

ShowHide Related Items >><<
IMAX Imax
$20.54 /

-0.37 (-1.77%)

IMAX Imax
$20.54 /

-0.37 (-1.77%)

10/22/21 Wells Fargo
Imax initiated with an Overweight at Wells Fargo
10/11/21 B. Riley
Imax price target raised to $30 from $28 at B. Riley
10/04/21 B. Riley
Strong openings 'another outlook boost' for exhibition group, says B. Riley
08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
IMAX Imax
$20.54 /

-0.37 (-1.77%)

IMAX Imax
$20.54 /

-0.37 (-1.77%)

IMAX Imax
$20.54 /

-0.37 (-1.77%)

IMAX Imax
$20.54 /

-0.37 (-1.77%)

Initiation
Imax initiated with an Overweight at Wells Fargo » 06:23
10/22/21
10/22
06:23
10/22/21
06:23
IMAX

Imax

$20.54 /

-0.37 (-1.77%)

Wells Fargo analyst…

Wells Fargo analyst Steven Cahall initiated coverage of Imax with an Overweight rating and $27 price target.

ShowHide Related Items >><<
IMAX Imax
$20.54 /

-0.37 (-1.77%)

IMAX Imax
$20.54 /

-0.37 (-1.77%)

10/11/21 B. Riley
Imax price target raised to $30 from $28 at B. Riley
10/04/21 B. Riley
Strong openings 'another outlook boost' for exhibition group, says B. Riley
08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
07/29/21 Barrington
Imax price target lowered to $22 from $27 at Barrington
IMAX Imax
$20.54 /

-0.37 (-1.77%)

IMAX Imax
$20.54 /

-0.37 (-1.77%)

IMAX Imax
$20.54 /

-0.37 (-1.77%)

IMAX Imax
$20.54 /

-0.37 (-1.77%)

Conference/Events
Imax participates in a conference call with B. Riley » 04:55
10/18/21
10/18
04:55
10/18/21
04:55
IMAX

Imax

$20.44 /

-0.075 (-0.37%)

Conference call with…

Conference call with management will be held on October 18 hosted by B. Riley.

ShowHide Related Items >><<
IMAX Imax
$20.44 /

-0.075 (-0.37%)

IMAX Imax
$20.44 /

-0.075 (-0.37%)

10/11/21 B. Riley
Imax price target raised to $30 from $28 at B. Riley
10/04/21 B. Riley
Strong openings 'another outlook boost' for exhibition group, says B. Riley
08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
07/29/21 Barrington
Imax price target lowered to $22 from $27 at Barrington
IMAX Imax
$20.44 /

-0.075 (-0.37%)

IMAX Imax
$20.44 /

-0.075 (-0.37%)

IMAX Imax
$20.44 /

-0.075 (-0.37%)

IMAX Imax
$20.44 /

-0.075 (-0.37%)

Recommendations
Imax price target raised to $30 from $28 at B. Riley » 07:39
10/11/21
10/11
07:39
10/11/21
07:39
IMAX

Imax

$21.29 /

-0.045 (-0.21%)

B. Riley analyst Eric…

B. Riley analyst Eric Wold raised the firm's price target on Imax to $30 from $28 and keeps a Buy rating on the shares. The analyst is "increasingly confident" in a pre-pandemic box office return in 2022. The best news for the exhibition industry came on September 10 when Disney (DIS) confirmed that the studio would eventually take the same stance on exclusive theatrical windows as the other major studios, Wold tells investors in a research note. And given "stronger in-theater spending patterns," both for ticket prices and concessions, the analyst increasingly believes exhibitor results could outperform in 2022 even if attendance remains slightly below 2019 levels. He increased estimates for Imax to reflect "positive slate moves into the quarter and stronger-than-expected demand trends."

ShowHide Related Items >><<
IMAX Imax
$21.29 /

-0.045 (-0.21%)

IMAX Imax
$21.29 /

-0.045 (-0.21%)

10/04/21 B. Riley
Strong openings 'another outlook boost' for exhibition group, says B. Riley
08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
07/29/21 Barrington
Imax price target lowered to $22 from $27 at Barrington
06/07/21 B. Riley
Box office trends improving into summer, says B. Riley
IMAX Imax
$21.29 /

-0.045 (-0.21%)

IMAX Imax
$21.29 /

-0.045 (-0.21%)

IMAX Imax
$21.29 /

-0.045 (-0.21%)

IMAX Imax
$21.29 /

-0.045 (-0.21%)

Conference/Events
Imax participates in a conference call with B. Riley » 12:34
10/08/21
10/08
12:34
10/08/21
12:34
IMAX

Imax

$21.40 /

+0.07 (+0.33%)

Conference call with…

Conference call with management will be held on October 18 hosted by B. Riley.

ShowHide Related Items >><<
IMAX Imax
$21.40 /

+0.07 (+0.33%)

IMAX Imax
$21.40 /

+0.07 (+0.33%)

10/04/21 B. Riley
Strong openings 'another outlook boost' for exhibition group, says B. Riley
08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
07/29/21 Barrington
Imax price target lowered to $22 from $27 at Barrington
06/07/21 B. Riley
Box office trends improving into summer, says B. Riley
IMAX Imax
$21.40 /

+0.07 (+0.33%)

IMAX Imax
$21.40 /

+0.07 (+0.33%)

IMAX Imax
$21.40 /

+0.07 (+0.33%)

IMAX Imax
$21.40 /

+0.07 (+0.33%)

Periodicals
'No Time to Die' on track to top $100M at U.S. box office in debut, CNBC says » 14:30
10/04/21
10/04
14:30
10/04/21
14:30
SONY

Sony

$106.63 /

-2.96 (-2.70%)

, AMZN

Amazon.com

$3,190.17 /

-89.56 (-2.73%)

, MCS

Marcus

$18.56 /

+0.625 (+3.49%)

, IMAX

Imax

$20.42 /

+0.69 (+3.50%)

, AMC

AMC Entertainment

$36.98 /

-1.46 (-3.80%)

, CNK

Cinemark

$21.02 /

+1.1 (+5.52%)

, NCMI

National CineMedia

$3.82 /

+0.15 (+4.09%)

, CNNWF

Cineworld Group

$1.09 /

+0.027 (+2.54%)

Upcoming James Bond film…

Upcoming James Bond film "No Time to Die" is slated to top $100M in theater ticket sales during its upcoming opening weekend in the U.S., CNBC's Sarah Whitten reports. The latest MGM flick is on pace to deliver a strong opening that could potentially top both pandemic-era records and ones set by previous Bond movies, Whitten says. Theater operators told CNBC that "No Time to Die" is outperforming advanced ticket sales estimates and, in many cases, is matching the presales for Sony's (SONY) "Venom: Let There Be Carnage." The Fly notes that MGM has agreed to be acquired by Amazon (AMZN). Publicly traded companies in the space include AMC Entertainment (AMC), Cinemark (CNK), Cineworld Group (CNNWF), Imax (IMAX), Marcus (MCS) and National CineMedia (NCMI). Reference Link

ShowHide Related Items >><<
SONY Sony
$106.63 /

-2.96 (-2.70%)

NCMI National CineMedia
$3.82 /

+0.15 (+4.09%)

MCS Marcus
$18.56 /

+0.625 (+3.49%)

IMAX Imax
$20.42 /

+0.69 (+3.50%)

CNK Cinemark
$21.02 /

+1.1 (+5.52%)

AMZN Amazon.com
$3,190.17 /

-89.56 (-2.73%)

AMC AMC Entertainment
$36.98 /

-1.46 (-3.80%)

SONY Sony
$106.63 /

-2.96 (-2.70%)

09/27/21 Cowen
Sony initiated with an Outperform at Cowen
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
07/27/21 Morgan Stanley
Sony upgraded to Overweight at Morgan Stanley on animation business growth
07/27/21 Morgan Stanley
Sony upgraded to Overweight from Equal Weight at Morgan Stanley
AMZN Amazon.com
$3,190.17 /

-89.56 (-2.73%)

09/30/21 RBC Capital
Amazon.com initiated with an Outperform at RBC Capital
09/29/21 DA Davidson
Recent pullback in Telos presents buying opportunity, says DA Davidson
09/29/21 MKM Partners
United Natural Foods price target raised to $59 from $46 at MKM Partners
09/27/21 BofA
Roku selloff overdone as streaming lead remains, says BofA
MCS Marcus
$18.56 /

+0.625 (+3.49%)

10/04/21 B. Riley
Strong openings 'another outlook boost' for exhibition group, says B. Riley
08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
08/09/21 Barrington
Marcus price target lowered to $22 from $25 at Barrington
06/07/21 B. Riley
Box office trends improving into summer, says B. Riley
IMAX Imax
$20.42 /

+0.69 (+3.50%)

07/29/21 Barrington
Imax price target lowered to $22 from $27 at Barrington
AMC AMC Entertainment
$36.98 /

-1.46 (-3.80%)

09/01/21
Fly Intel: Top five analyst downgrades
09/01/21 Macquarie
AMC Entertainment downgraded to Underperform from Neutral at Macquarie
08/24/21 MKM Partners
Slow box office to make AMC Entertainment recovery difficult, says MKM Partners
CNK Cinemark
$21.02 /

+1.1 (+5.52%)

06/02/21 Goldman Sachs
Cinemark downgraded to Sell from Neutral at Goldman Sachs
NCMI National CineMedia
$3.82 /

+0.15 (+4.09%)

06/24/21 B. Riley
National CineMedia price target raised to $7 from $6 at B. Riley
CNNWF Cineworld Group
$1.09 /

+0.027 (+2.54%)

06/25/21 Berenberg
Cineworld Group price target raised to 85 GBp from 70 GBp at Berenberg
05/05/21 Barclays
Cineworld Group reinstated with an Equal Weight at Barclays
03/29/21 JPMorgan
Cineworld Group price target raised to 74 GBp from 50 GBp at JPMorgan
SONY Sony
$106.63 /

-2.96 (-2.70%)

NCMI National CineMedia
$3.82 /

+0.15 (+4.09%)

MCS Marcus
$18.56 /

+0.625 (+3.49%)

IMAX Imax
$20.42 /

+0.69 (+3.50%)

CNK Cinemark
$21.02 /

+1.1 (+5.52%)

AMZN Amazon.com
$3,190.17 /

-89.56 (-2.73%)

AMC AMC Entertainment
$36.98 /

-1.46 (-3.80%)

SONY Sony
$106.63 /

-2.96 (-2.70%)

IMAX Imax
$20.42 /

+0.69 (+3.50%)

AMZN Amazon.com
$3,190.17 /

-89.56 (-2.73%)

AMC AMC Entertainment
$36.98 /

-1.46 (-3.80%)

SONY Sony
$106.63 /

-2.96 (-2.70%)

NCMI National CineMedia
$3.82 /

+0.15 (+4.09%)

MCS Marcus
$18.56 /

+0.625 (+3.49%)

IMAX Imax
$20.42 /

+0.69 (+3.50%)

CNK Cinemark
$21.02 /

+1.1 (+5.52%)

AMZN Amazon.com
$3,190.17 /

-89.56 (-2.73%)

AMC AMC Entertainment
$36.98 /

-1.46 (-3.80%)

SONY Sony
$106.63 /

-2.96 (-2.70%)

IMAX Imax
$20.42 /

+0.69 (+3.50%)

CNK Cinemark
$21.02 /

+1.1 (+5.52%)

AMZN Amazon.com
$3,190.17 /

-89.56 (-2.73%)

AMC AMC Entertainment
$36.98 /

-1.46 (-3.80%)

Recommendations
Strong openings 'another outlook boost' for exhibition group, says B. Riley » 08:20
10/04/21
10/04
08:20
10/04/21
08:20
CNK

Cinemark

$19.92 /

+0.715 (+3.72%)

, IMAX

Imax

$19.73 /

+0.73 (+3.84%)

, MCS

Marcus

$17.95 /

+0.5 (+2.87%)

, NCMI

National CineMedia

$3.67 /

+0.105 (+2.95%)

The stronger than…

The stronger than anticipated opening weekends in the U.S. for "Venom: Let There Be Carnage" and overseas for "No Time to Die" should help to provide "another outlook boost" for the exhibition group "after the impressive run for the stocks over the past few weeks," B. Riley analyst Eric Wold tells investors in a research note. Even in the midst of increasing concerns around the delta variant and mask mandates being reinstated within some regions, moviegoers are at the point where they "will push through any of these headwinds if the film slate is strong enough and studios hold the line with the release calendar," says Wold. The analyst reiterates Buy ratings on Cinemark (CNK), Imax (IMAX), Marcus (MCS) and National CineMedia (NCMI).

ShowHide Related Items >><<
NCMI National CineMedia
$3.67 /

+0.105 (+2.95%)

MCS Marcus
$17.95 /

+0.5 (+2.87%)

IMAX Imax
$19.73 /

+0.73 (+3.84%)

CNK Cinemark
$19.92 /

+0.715 (+3.72%)

CNK Cinemark
$19.92 /

+0.715 (+3.72%)

08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
06/07/21 B. Riley
Box office trends improving into summer, says B. Riley
06/02/21 Goldman Sachs
Cinemark downgraded to Sell from Neutral at Goldman Sachs
04/19/21 Morgan Stanley
Cinemark price target raised to $25 from $17 at Morgan Stanley
IMAX Imax
$19.73 /

+0.73 (+3.84%)

07/29/21 Barrington
Imax price target lowered to $22 from $27 at Barrington
06/02/21
Fly Intel: Top five analyst downgrades
MCS Marcus
$17.95 /

+0.5 (+2.87%)

08/09/21 Barrington
Marcus price target lowered to $22 from $25 at Barrington
03/24/21 B. Riley
Disney 'day-and-date' decision negative for exhibitors, says B. Riley
NCMI National CineMedia
$3.67 /

+0.105 (+2.95%)

06/24/21 B. Riley
National CineMedia price target raised to $7 from $6 at B. Riley
04/07/21
Fly Intel: Top five analyst upgrades
NCMI National CineMedia
$3.67 /

+0.105 (+2.95%)

MCS Marcus
$17.95 /

+0.5 (+2.87%)

IMAX Imax
$19.73 /

+0.73 (+3.84%)

CNK Cinemark
$19.92 /

+0.715 (+3.72%)

CNK Cinemark
$19.92 /

+0.715 (+3.72%)

NCMI National CineMedia
$3.67 /

+0.105 (+2.95%)

MCS Marcus
$17.95 /

+0.5 (+2.87%)

IMAX Imax
$19.73 /

+0.73 (+3.84%)

CNK Cinemark
$19.92 /

+0.715 (+3.72%)

IMAX Imax
$19.73 /

+0.73 (+3.84%)

CNK Cinemark
$19.92 /

+0.715 (+3.72%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.